Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New directions for predicting carcinogenesis

B Schwetz1, D Gaylor

  • 1Food and Drug Administration/National Center for Toxicological Research, Jefferson, Arkansas 72079-9502, USA.

Molecular Carcinogenesis
|December 16, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Report of an Expert Panel on the reanalysis by of a 90-day study conducted by Monsanto in support of the safety of a genetically modified corn variety (MON 863).

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2007
Same author

Threshold analysis of selected dose-response data for endocrine active chemicals.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2001
Same author

Rodent carcinogenicity studies on magnetic fields.

Toxicologic pathology·1999
Same author

Procedures for calculating benchmark doses for health risk assessment.

Regulatory toxicology and pharmacology : RTP·1999
Same author

No threshold dose for estradiol-induced sex reversal of turtle embryos: how little is too much?

Environmental health perspectives·1999
Same author

Use of Druckrey analysis to quantitatively evaluate the chemopreventive efficacy of N-difluoromethylornithine (DFMO), a prototype proliferation inhibitor.

Mutation research·1998
Same journal

Acylglycerol Kinase Sensitizes Glioblastoma to Temozolomide via Limiting Mitochondrial Damage Related Cellular Senescence.

Molecular carcinogenesis·2026
Same journal

Accelerated Biological Aging Increases the Risk of Head and Neck Cancer: Insights From Genetic Instruments of Epigenetic Clocks.

Molecular carcinogenesis·2026
Same journal

Colorectal Cancer Liver Metastasis-Associated Ferroptosis-Related Genes Modulate Lipid Peroxidation in Colorectal Cancer Cells.

Molecular carcinogenesis·2026
Same journal

Ubiquitin Specific Peptidase 48 Deubiquitinates METTL3 to Modulate Ferroptosis in Gastric Cancer Cells.

Molecular carcinogenesis·2026
Same journal

Prevention of Myc-Driven Prostate Cancer in Mice by Oral Administration of Sulforaphane.

Molecular carcinogenesis·2026
Same journal

Association of Expression of YTH-Domain Family Protein 3 (YTHDF3) With Brain Metastases and Unfavorable Survival in Patients With Stage IV Lung Adenocarcinoma.

Molecular carcinogenesis·2026
See all related articles

Current carcinogenicity testing is lengthy and costly. New approaches aim to use mechanistic data for faster, more cost-effective cancer risk assessment, potentially replacing traditional rodent studies.

Area of Science:

  • Toxicology
  • Carcinogenesis Research
  • Regulatory Science

Background:

  • Standard carcinogenicity testing involves 2-year rodent studies, preceded by genetic and subchronic toxicity tests.
  • These studies are expensive, time-consuming (5+ years), and often lack mechanistic insights for risk assessment.

Purpose of the Study:

  • To explore alternative approaches for carcinogenicity testing.
  • To develop methods providing more mechanistic information for cancer risk assessment.
  • To enable regulatory acceptance of novel testing strategies.

Main Methods:

  • Review of current carcinogenicity testing paradigms.
  • Exploration of data-driven decision-making based on a profile of evidence.
  • Development of alternative assays focusing on mechanistic understanding.

Related Experiment Videos

Main Results:

  • Current methods are resource-intensive and lack mechanistic detail.
  • Alternative approaches are being developed to provide mechanistic data.
  • A shift towards data profiling over single-test outcomes is proposed.

Conclusions:

  • New carcinogenicity testing strategies can offer mechanistic insights and efficiency.
  • Regulatory acceptance is crucial for advancing the field of carcinogenesis.
  • Future assessments may rely on a comprehensive data profile rather than solely long-term rodent bioassays.